Associated Papers
A Case-Control Study Supports Genetic Contribution of the PON Gene Family in Obesity and Metabolic Dysfunction Associated Steatotic Liver Disease.
Van Dijck E et al.
Antioxidants (basel, Switzerland), 2024
39334710 (PubMed )
Supplement: antioxidants-13-01051-s001.zip › antioxidants-3169066-supplementary.pdf
Decoding variants in drug-metabolizing enzymes and transporters in solid tumor patients by whole-exome sequencing.
Aboul-Soud MAM et al.
Saudi Journal of Biological Sciences, 2021
33424349 (PubMed )
Supplement: mmc1.xlsx › Sheet1
Targeted next generation sequencing as a tool for precision medicine.
Gulilat M et al.
Bmc Medical Genomics, 2019
31159795 (PubMed )
Supplement: 12920_2019_527_MOESM1_ESM.xlsx › Table_S6
Oligogenic genetic variation of neurodegenerative disease genes in 980 postmortem human brains.
Keogh MJ et al.
Journal of Neurology, Neurosurgery, and Psychiatry, 2018
29332010 (PubMed )
Supplement: jnnp-2017-317234supp001.pdf
Novel common and rare genetic determinants of paraoxonase activity: FTO, SERPINA12, and ITGAL.
Kim DS et al.
Journal of Lipid Research, 2013
Paraoxonase gene mutations in amyotrophic lateral sclerosis.
Ticozzi N et al.
Annals of Neurology, 2010
Paraoxonase 1 status as a risk factor for disease or exposure.
Richter RJ et al.
Advances in Experimental Medicine and Biology, 2010
Role of paraoxonase (PON1) status in pesticide sensitivity: genetic and temporal determinants.
Furlong CE et al.
Neurotoxicology, 2005
Select a paper to view details